文献速递中医骨伤中医康复中药与中成药合理使用

骨质疏松性椎体压缩骨折术后闭环管理框架:生物传感器监测与中药复方整合

A proposed closed-loop framework for postoperative management of OVCF integrating biosensor-enabled monitoring and traditional Chinese medicine formulas: from dynamic assessment to precision intervention.
PubMed 文献 · Front Pharmacol · 2026-03-05

本文为叙述性综述与概念性视角文章,综合生物传感器即时检测(重点为OPECT)及补肾活血类中药复方的机制药理学证据,提出将高频骨转换标志物监测与生物标志物指导的术后整合管理相连接的闭环框架。文章未报告原始临床实施数据,框架旨在指导未来转化研究、标准化及前瞻性临床验证。

要点

  • 传统BMD与影像学评估存在固有延迟,骨转换标志物可反映实时骨重建动态但常规难以高频检测。
  • 生物传感器即时检测(尤其OPECT)为高频监测骨转换标志物提供技术可能。
  • 补肾活血类中药复方的机制药理学证据支持其用于术后整合管理,但需前瞻性验证。

核心结论

  • 提出一个将高频骨转换标志物监测与生物标志物指导的术后整合管理相连接的闭环框架,用于OVCF术后管理。
  • 该框架旨在指导未来转化研究、标准化及前瞻性临床验证,而非报告原始临床实施数据。

研究设计与样本

  • 叙述性综述与概念性视角文章,综合近期生物传感器即时检测进展(重点为OPECT)及补肾活血类中药复方的机制药理学证据。

主要发现

  • 传统BMD与影像学评估存在固有延迟,而反映实时骨重建动态的骨转换标志物在常规护理中难以频繁测量。
  • 常用抗骨质疏松药物可能受限于可测量反应起效延迟及特定人群长期耐受性担忧。
  • 生物传感器即时检测(重点为OPECT)及补肾活血类中药复方的机制药理学证据为闭环框架提供基础。

临床怎么用

  • 可考虑将高频骨转换标志物监测纳入OVCF术后管理,以生物标志物信息优化整合管理方案。
  • 补肾活血类中药复方可作为术后整合管理的组成部分,但需在框架指导下开展前瞻性临床验证。

局限性

  • 本文未报告原始临床实施数据,所提框架尚需未来转化研究、标准化及前瞻性临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Postoperative management of osteoporotic vertebral compression fracture (OVCF) remains challenging because conventional bone mineral density (BMD) and imaging assessments are intrinsically delayed, while bone turnover markers (BTMs) that reflect real-time remodeling dynamics are difficult to measure frequently in routine care. In parallel, commonly used anti-osteoporotic medications may be limited by delayed onset of measurable response and concerns regarding long-term tolerability in certain populations. This article is a narrative review and conceptual perspective that synthesizes recent advances in biosensor-enabled point-of-care testing-highlighting organic optoelectrochemical transistors (OPECT)-and mechanistic pharmacology evidence for kidney-tonifying and blood-activating traditional Chinese medicine (TCM) formulas. On this basis, we propose a closed-loop framework that links high-frequency BTM monitoring to biomarker-informed optimization of postoperative integrative management. Importantly, this work does not report original clinical implementation data; the proposed framework is intended to guide future translational research, standardization, and prospective clinical validation.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wang C, Yu Z, Liao Y, et al. A proposed closed-loop framework for postoperative management of OVCF integrating biosensor-enabled monitoring and traditional Chinese medicine formulas: from dynamic assessment to precision intervention. Front Pharmacol. 2026. PMID: 41868126. doi:10.3389/fphar.2026.1758723

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。